THE MAPH SCORE PREDICTS CORONARY SLOW FLOW. A RETROSPECTIVE CASE-CONTROLLED STUDY

Basit Öğe Kaydı
dc.authoridAydin, Cihan/0000-0002-1401-5727
dc.authoridCekici, Yusuf/0000-0002-4585-3707
dc.authoridtoprak, kenan/0000-0001-8923-8709
dc.authoridYildirim, Arafat/0000-0002-2798-7488
dc.authoridKaplangoray, Mustafa/0000-0002-4297-1820
dc.contributor.authorKaplangoray, Mustafa
dc.contributor.authorToprak, Kenan
dc.contributor.authorAydin, Cihan
dc.contributor.authorCekici, Yusuf
dc.contributor.authorYildirim, Arafat
dc.contributor.authorAbacioglu, Ozge Ozcan
dc.date.accessioned2024-10-29T17:58:59Z
dc.date.available2024-10-29T17:58:59Z
dc.date.issued2024
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractAim The MAPH score is a new score that combines mean platelet volume (MPV), hematocrit, and total protein, which are markers of whole blood viscosity (WBV). We aimed to investigate the relationship between the MAPH score and the coronary slow flow phenomenon (CSF). Material and methods A total of 201 patients were included in the study. 105 had CSF and 96 had normal coronary flow (NCF). Coronary flow was measured by the Thrombolysis in Myocardial Infarction frame count (TFC) method. The patients' MPV, age, hematocrit, and total protein were recorded. High (HSR) and low shear rates (LSR) were calculated, based on total protein and hematocrit values. Cut-off values for CSF were determined using the Youden's index, and the score was determined as 0 or 1 according to the cut-off values. The sum of these scores was the MAPH score. Results The mean age of the patients included in the study was 51.1 +/- 7.9 (n=201, 54.2 % male). Hyperlipidemia, DM, and HT rates of both groups were similar, but the mean age of the CSF group was higher (p=0.773; p=0.549; p=0.848; p <0.001, respectively). Total protein, MPV,hematocrit, HSR and LSR were higher in the CSF group (p< 0.001, for all values). Comparative receiver operating characteristic (ROC) curve analysis showed that the performance of the MAPH score in predicting CSF is better than the performance of these parameters separately. Conclusion A new score, the MAPH score, may be used to identify the presence of CSF
dc.identifier.doi10.18087/cardio.2024.2.n2322
dc.identifier.issn0022-9040
dc.identifier.issue2en_US
dc.identifier.pmid38462806
dc.identifier.scopus2-s2.0-85187465539
dc.identifier.scopusqualityQ4
dc.identifier.urihttps://doi.org/10.18087/cardio.2024.2.n2322
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14580
dc.identifier.volume64
dc.identifier.wosWOS:001188199600007
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherRussian Heart Failure Soc
dc.relation.ispartofKardiologiya
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCoronary slow flow
dc.subjectMAPH score
dc.subjectshear rate
dc.subjectTIMI frame count
dc.subjectwhole blood viscosity
dc.titleTHE MAPH SCORE PREDICTS CORONARY SLOW FLOW. A RETROSPECTIVE CASE-CONTROLLED STUDY
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu